Business · 27/10/2022Updated: 10/17/2026 · 1 min read
FDA Postpones Joint Meeting of Advisory Committees
Summary
The FDA has rescheduled the joint meeting of the Nonprescription Drugs Advisory Committee and the Obstetrics, Reproductive and Urologic Drugs Advisory Committee, originally set for November 18, 2022, and will announce new dates in the Federal Register.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →